OOIR: Observatory of International Research

Papers

(The median citation count of Biosocieties is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Publisher Correction: Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria	14
Sexual health as surplus: the marketization of PrEP in Taiwan	12
“Black race”, “Schwarze Hautfarbe”, “Origine africaine”, or “Etnia nera”? The absent presence of race in European pharmaceutical regulation	12
Conceptualization of genotype–phenotype relationships and the assessment of risk in advertising of direct-to-consumer and preimplantation polygenic tests	11
Deploying nationalist discourses to reduce sex-, gender- and HIV-related stigma in Thailand	10
Discipline for pleasure: a new governmentality of HIV prevention	10
Cell freezing and the biology of inexorability: on cryoprotectants and chemical time	10
“An entire career in 10 seconds”: on protein chemistry, AI, and the threat of obsolescence	9
Mapping ‘bio geo-body’ of Southeast Asia: strategic differentiation and identification of ethnic identity in Vietnam and Singapore	8
Bleak Biopolitics and Abolitionist Aspirations: Recent Books on Race	7
Hormonal stories: a new materialist exploration of hormonal emplotment in four case studies	7
Agri-food tech’s building block: narrating protein, agnostic of source, in the face of crisis	7
Molecular sovereignties: patients, genomes, and the enduring biocoloniality of intellectual property	7
Adjusting the analytical aperture: propositions for an integrated approach to the social study of reproductive technologies	7
“The elephant in the room”: social responsibility in the production of sociogenomics research	6
What to do with the new molecular publics: the vernacularization of pathogen genomics and the future of infectious disease biosocialities	6
Post-identifiability in changing sociotechnological genomic data environments	6
Challenges in public policy for the implementation of pharmacogenetic tests in Europe	6
Ectogenesis, inequality, and coercion: a reproductive justice-informed analysis of the impact of artificial wombs	5
Epistemology of the side effect: anecdote and evidence in the digital age	5
Openness in donor conception families	5
Accept no limits: biocontainment and the construction of a safer space for experimentation in xenobiology as a legacy of Asilomar	5
Psychedelic innovations and the crisis of psychopharmacology	4
Making death through producing life: Necrovalue and the political economy of death	4
Negotiating the necessity of biomedical animal use through relations with vulnerability	4

Beyond controversies in child mental health: negotiating autism and ADHD diagnosis in France and Brazil	4
Introduction to the special issue: Politics of suspension? Time, space, and control in cryopreservation practices	4
Value-creation in the health data domain: a typology of what health data help us do	4
It’s all about kids, kids, kids! Negotiating reproductive citizenship and patient-centred care in ‘factory IVF’	4
Pharmaceutical innovation and its crisis: drug markets, screening, and the dialectics of value	4
Afterword: the politics of suspension as an analytical gestalt switch	3
Correction: An imagined future community: Taiwan Biobank, Taiwanese genome, and nation-building	3
Navigating biosafety concerns within COVID-19 do-it-yourself (DIY) science: an ethnographic and interview study	3
Styles of thought in healthcare governance: A situational analysis of English PrEP discourse 2016–2020	3
Foetal programming meets human capital: biological plasticity, development, and the limits to the economization of life	3
Allostatic load: historical origins, promises and costs of a recent biosocial approach	3
Correction to: The other face of medical globalization? Pharmaceutical data, prescribing trends, and the social localization of psychostimulants	3
Anticipating and suspending: the chronopolitics of cryopreservation	2
Correction to: Epidemiologists’ ambivalence towards the epigenetics of social adversity	2
Good donors, bad donors and oddities in the family tree: genomics, donation and reproductive citizenship in Finnish egg donor accounts	2
Formatting patient knowledge and channelling participation: how patient organisations work under authoritarianism	2
Antibiotics in the environment: molecularisation, drug resistance and pharmaceutical pollution in India	2
To wish you well: the biopolitical subjectivities of medical crowdfunders during and after Aotearoa New Zealand’s COVID-19 lockdown	2
Making valuable health: pharmaceuticals, global capital and alternative political economies	2
“Is your brain in danger of overheating?”: neurobiologizing the labouring subject in cognitive capitalism	2
Donors we choose: race, nation and the biopolitics of (queer) assisted reproduction in Scandinavia	2
Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria	2
Inscrutable futures: biotechnology, architecture, and planetary ecology in late industrial China	2
‘Nonetheless biosocial’: experiences and embodied knowledge of birth cohort participants in the UK and Brazil	2
Correction: Reproducing the normal and the pathological in personalized cancer medicine clinical trials	2
Population anxieties in constituting Nordic welfare state futures: affective biopolitics in the age of environmental crises	2
The normal is pathological: semi-conscious brains, mindless habits, and the paradoxical science of mindfulness	2
Diversity via datafication? Digital patient records and citizenship for sexuality and gender diverse people	2
Correction: Core values of genomic citizen science: results from a qualitative interview study	2
The other face of medical globalization? Pharmaceutical data, prescribing trends, and the social localization of psychostimulants	1
Living in the era of codes: a reflection on China’s health code system	1
Suspending life, controlling change: cryotechnology, genetic identity, and ecological separation	1
Reproducing the normal and the pathological in personalized cancer medicine clinical trials	1
‘Our biology is listening’: biomarkers as molecular vestiges of early life and the production of positive childhood experiences in behavioral epigenetics	1
More than sample providers: how genetic researchers in Pakistan mobilized a prenatal diagnostic service for thalassemia	1
‘Braining’ psychiatry: an investigation into how complexity is managed in the practice of neuropsychiatric research	1
Paradoxical bodies: negotiating biomedical fix, responsibility, and care in a weight-loss surgery clinic	1
The social shaping of biotechnological innovation. The case of Covid-19 protein vaccine in Cuba and the US	1
In whose pockets? How small Danish patient organisations balance legitimacy, representation and dependency in collaboration with public sector medical researchers and the life science industry	1
Making epistemic goods compatible: knowledge-making practices in a lifestyle intervention RCT on mindfulness and compassion meditation	1
Reprowebs: a conceptual approach to elasticity and change in the global assisted reproduction industry	1
Guardians of ableist family formation: the legitimation work of Danish abortion committees in cases of termination for fetal anomaly	1
“Being useful, I think it's the result of a sick society”: Critical reflections on reproductive politics and markets by women freezing their eggs in Spain	1
The emergence of multimorbidity as a matter of concern: a critical review	1
The effects of COVID-19 on imagined reproductive futures	1
‘Healthy’ for whom? ‘Healthy’ food’s effectivities, avocados, and the production of differentiated bodies	1